Role of phosphodiesterase 4 expression in the Epac1 signaling-dependent skeletal muscle hypertrophic action of clenbuterol-Reference-Cited by-同舟云学术

Role of phosphodiesterase 4 expression in the Epac1 signaling-dependent skeletal muscle hypertrophic action of clenbuterol

Published:2016-05 Issue:10 Volume:4 Page:e12791
ISSN:2051-817X
Container-title:Physiological Reports
language:en
Short-container-title:Physiol Rep

Author:

Ohnuki Yoshiki¹,Umeki Daisuke¹²,Mototani Yasumasa¹,Shiozawa Kouichi¹,Nariyama Megumi¹³,Ito Aiko¹²,Kawamura Naoya¹⁴,Yagisawa Yuka¹²,Jin Huiling⁵,Cai Wenqian⁵,Suita Kenji¹⁵,Saeki Yasutake¹,Fujita Takayuki⁵,Ishikawa Yoshihiro⁵,Okumura Satoshi¹⁵

Affiliation:

1. Department of Physiology; Tsurumi University School of Dental Medicine; Yokohama Japan

2. Department of Orthodontics; Tsurumi University School of Dental Medicine; Yokohama Japan

3. Department of Pediatric Dentistry; Tsurumi University School of Dental Medicine; Yokohama Japan

4. Department of Periodontology; Tsurumi University School of Dental Medicine; Yokohama Japan

5. Cardiovascular Research Institute; Yokohama City University Graduate School of Medicine; Yokohama Japan

Funder

Japan Society for Promotion of Science (JSPS) KAKENHI Grant

Grant-in-Aid for Scientific Research on Innovative Areas

MEXT-Supported Program for the Strategic Research Foundation at Private Universities

Takeda Science Foundation

Yokohama Foundation for Advanced Medical Science

Mitsubishi Pharma Research Foundation

Research for Promoting Technological Seeds A

Yokohama Academic Foundation

2010 Commercialization Promotion Program for Biotechnology-related Studies

Grant for Research, Development Project II of Yokohama City University

Suzuken Memorial Foundation

Research Promotion Grant from the Society for Tsurumi University School of Dental Medicine

Academic Contribution from Pfizer, Japan

Research Foundation for Community Medicine

Naito Foundation

Publisher

Wiley

Subject

Physiology (medical),Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.14814/phy2.12791/fullpdf

Reference67 articles.

1. IGF and myostatin pathways are respectively induced during the earlier and the later stages of skeletal muscle hypertrophy induced by clenbuterol, a β2-adrenergic agonist;Abo;Cell Biochem. Funct.,2012

2. Pharmacological stimulation of type 5 adenylyl cyclase stabilizes heart rate under both microgravity and hypergravity induced by parabolic flight;Bai;J. Pharmacol. Sci.,2012

3. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo;Ball;Br. J. Pharmacol.,1991

4. Specific interactions between Epac1, b-arrestin2 and PDE4D5 regulate beta-adrenergic receptor subtype differential effects on cardiac hypertrophic signaling;Berthouze-Duquesnes;Cell. Signal.,2013

5. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study;Birks;Circulation,2011

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suppression of FoxO1 mRNA by β ₂ ‐adrenoceptor–cAMP signaling through miR‐374b‐5p and miR‐7a‐1‐3p in C2C12 myotubes;FEBS Open Bio;2022-02-07

2. Effects of occlusal disharmony on cardiac fibrosis, myocyte apoptosis and myocyte oxidative DNA damage in mice;PLOS ONE;2020-07-27

3. Survey of clenbuterol in bovine muscle and liver in Ecuador;Food Additives & Contaminants: Part B;2020-03-09

4. Effects of clenbuterol administration on mitochondrial morphology and its regulatory proteins in rat skeletal muscle;Physiological Reports;2019-10

Early effects of roflumilast on insulin sensitivity in adults with prediabetes and overweight/obesity involve age-associated fat mass loss – results of an exploratory study

;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2019-05